Web Results



Nov 30, 2016 ... TAYLOR v. BAYER HEALTHCARE PHARMACEUTICALS, INC. et al (2:16-cv- 08906), New Jersey District Court, Filed: 11/30/2016 ...

Bayer Healthcare Pharmaceuticals, Inc., et al v. River's Edge ...


Bayer Healthcare Pharmaceuticals, Inc., et al v. River's Edge Pharmaceuticals, LLC et al. 1:11-cv-01634; Filed: 05/19/2011; Case Updated Daily; Latest Docket ...

2013 Northern District of California U.S. Federal District Court Case ...


Wade v. Gatan, Inc. et al. Date: December 20, 2013. Docket Number: 4: ... Baker v . Bayer HealthCare Pharmaceuticals Inc. Date: December 19, 2013 .... Docket Number: 5:2013cv01007. Tatum v. Buckley Date: November 21, 2013

Molecular and Functional MRI of the Tumor Microenvironment - NCBI


Apr 15, 2008 ... ... Bracco Diagnostics, Inc.), gadopentetate dimeglumine (Magnevist; Bayer HealthCare Pharmaceuticals Inc.), gadoversetamide (OptiMARK; .... Laking GR, West C, Buckley DL, et al. ... Raman V, Artemov D, Pathak AP, et al.

MRI-based prediction of pulsed high-intensity focused ultrasound ...


Apr 1, 2013 ... Gadolinium contrast (Magnevist, Bayer HealthCare Pharmaceuticals Inc., Wayne, NJ) T1-weighted CE images were extracted from the ..... Frenkel V, Etherington A, Greene M, et al. ... Tofts PS, Brix G, Buckley DL, et al.

Measurement of glomerular filtration rate by dynamic contrast ... - NCBI


Apr 13, 2016 ... 2004; Buckley et al. .... weight Gd‐DTPA (Magnevist<sup>®</sup>; Bayer HealthCare Pharmaceuticals, ... 2004), and fits the data from the postaortic rise (Hackstein et al. ... values per volume of renal parenchyma (GFRV in min<sup>−1</sup>), and these ... T1‐ weighted images using Amira (Visage Imaging, Inc., San Diego, CA).

Association of fish oil supplement use with preservation of brain ...


Jun 18, 2014 ... AD, M = 3.30, 95% CI, 1.57–5.03, P < .001; MCI vs. ..... AstraZeneca; Bayer HealthCare; BioClinica, Inc; Biogen Idec, Inc; Bristol-Myers Squibb Company; Eisai Inc; Elan Pharmaceuticals, Inc; Eli Lilly and Company; F. Hoffmann-La Roche ... Sinn N, Milte CM, Street SJ, Buckley JD, Coates AM, Petkov J, et al.

Use of Florbetapir-PET for Imaging β-Amyloid Pathology | Clinical ...


Jan 19, 2011 ... Koole M, Lewis DM, Buckley C, et al. ... Hulette CM, Welsh-Bohmer KA, Murray MG, et al. .... Author Affiliations: Avid Radiopharmaceuticals, Philadelphia, ..... amyloid on florbetapir-PET (SUVr vs semiquantitative visual score: Bonferroni ρ, .... Radiopharmaceuticals, Bayer Healthcare Inc, and GE Healthcare.

Dependence of DCE-MRI biomarker values on analysis algorithm


Jul 24, 2015 ... wCVs were significantly smaller for ve, and larger for kep, with ... Citation: Ng CS, Wei W, Bankson JA, Ravoori MK, Han L, Brammer DW, et al. .... (Magnevist, Bayer Healthcare Pharmaceuticals, Wayne, NJ), via an .... Plotting was performed using Spotfire S+ 8.2 (TIBCO Software Inc., Somerville, MA).



Aug 26, 2015 ... Jonathan Siegel. Bayer HealthCare Pharmaceuticals Inc. ... Treatment Sequencing vs. Mechanism of .... futility boundary in its 2nd interim analysis ( Ribas et al., 2008). ..... Buckley, J. Introduction to Rare Event Simulation.

More Info

Bayer HealthCare LLC et al v. Mylan Pharmaceuticals Inc.


Bayer HealthCare LLC et al v. Mylan Pharmaceuticals Inc. 1:15-cv-00114; Filed: 01/30/2015; Case Updated Daily; Latest Docket Entry: 11/14/2016; PACER.

Frederick W. Misakian v. Bayer Healthcare Pharmaceuticals, Inc. Et ...


Frederick W. Misakian v. Bayer Healthcare Pharmaceuticals, Inc. Et Al, Case No. CGC 15 547365 in the Superior Court of California, County of San Francisco.

Bayer Schering Pharma AG v. Lupin, Ltd.


DC, for defendants-appellees Lupin Ltd, et al. ... BAYER SCHERING PHARMA v. LUPIN LTD. 4. Ltd. v. Forest Labs., Inc., 527 F.3d 1278, 1282 (Fed. Cir. 2008).